ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 67 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $105,047,460 | -24.5% | 5,236,663 | +6.2% | 0.00% | 0.0% |
| Q2 2023 | $139,051,970 | +90.6% | 4,929,173 | +16.2% | 0.00% | +50.0% |
| Q1 2023 | $72,938,578 | -12.9% | 4,240,615 | +1.9% | 0.00% | 0.0% |
| Q4 2022 | $83,785,400 | -5.8% | 4,160,149 | +1.3% | 0.00% | -33.3% |
| Q3 2022 | $88,942,000 | -29.5% | 4,106,261 | -8.6% | 0.00% | -25.0% |
| Q2 2022 | $126,234,000 | -15.6% | 4,492,335 | +38.6% | 0.00% | 0.0% |
| Q1 2022 | $149,520,000 | -44.2% | 3,240,585 | +1.7% | 0.00% | -33.3% |
| Q4 2021 | $267,898,000 | +28.4% | 3,186,986 | +1.8% | 0.01% | +20.0% |
| Q3 2021 | $208,709,000 | +38.4% | 3,131,885 | +10.5% | 0.01% | +25.0% |
| Q2 2021 | $150,813,000 | +43.7% | 2,834,824 | +17.2% | 0.00% | +33.3% |
| Q1 2021 | $104,954,000 | -13.9% | 2,418,848 | +3.1% | 0.00% | -25.0% |
| Q4 2020 | $121,857,000 | +228.7% | 2,346,137 | +106.9% | 0.00% | +300.0% |
| Q3 2020 | $37,068,000 | -6.7% | 1,133,967 | +37.1% | 0.00% | 0.0% |
| Q2 2020 | $39,709,000 | – | 826,942 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,426,095 | $111,940,000 | 6.63% |
| Paradigm Biocapital Advisors LP | 287,577 | $13,269,000 | 3.51% |
| Avidity Partners Management LP | 3,176,999 | $146,587,000 | 3.05% |
| Integral Health Asset Management, LLC | 215,000 | $9,920,000 | 2.58% |
| Matrix Capital Management Company, LP | 4,349,279 | $200,676,000 | 2.41% |
| Affinity Asset Advisors, LLC | 207,500 | $9,574,000 | 1.53% |
| Ikarian Capital, LLC | 202,203 | $9,329,000 | 1.23% |
| Ghost Tree Capital, LLC | 80,000 | $3,691,000 | 0.80% |
| Eventide Asset Management | 761,000 | $35,113,000 | 0.55% |
| Perceptive Advisors | 501,509 | $23,140,000 | 0.46% |